Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • Deccan Health Care...

    Deccan Health Care Limited aims for IPO on December 18

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-12-17T09:25:59+05:30  |  Updated On 17 Dec 2018 9:25 AM IST
    Deccan Health Care Limited aims for IPO on December 18

    The net proceeds will be utilised for repayment/prepayment of certainly secured borrowings availed by the Deccan Health Care Limited, purchase of plant & machinery and related civil work as well as general corporate purposes.


    Mumbai: Health product manufacturing company, Deccan Health Care Limited, on Thursday announced that it will hit the capital market with an initial public offer of 42,12,000 equity shares of face value of Rs 10 each to raise capital of around 40 crores for repayment of loans and other purposes.


    The price band of IPO, fixed in the price band of Rs 95 to Rs 100 per equity share, will open on December 18 and close on Dec 20. The offer comprises of fresh issue of 22,12,000 equity shares by the company and 20,00,000 equity shares for sale by the two shareholders (14,00,000 equity shares by Hitesh Patel and other 6,00,000 by Meenakshi Gupta), announced managing director of the company Pinto Gupta here.


    Of the total offer, 2,11,200 equity shares of face value of Rs 10 are reserved for subscription, while 40,00,800 equity shares of face value of Rs 10 each is the net offer.


    The offer and the net offer will constitute 26.81 per cent and 25.46 pc, respectively, of the fully-diluted post-offer, paid-up equity share capital of the company, he informed.


    The net proceeds will be utilised for repayment/prepayment of certainly secured borrowings availed by the company, purchase of plant & machinery and related civil work as well as general corporate purposes.


    Pantomath Capital Advisors Private Limited is the book running lead manager to the issue, whereas Bigshare Services Private Ltd is the registrar to the issue, Mr Gupta added.


    Hyderabad based nutraceutical maker Deccan Healthcare manufactures and sells about 1,500 formulations of micronutrients called nutraceuticals for hair care, skin care, heart care, and immunity building.


    Read Also: Shanghai Junshi Biosciences seeks up to $414 million in Hong Kong IPO
    Bigshare Services Private LtdBSEDeccan Health CareIPOPantomath Capital Advisors
    Source : With input

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok